Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Female Breast Carcinoma × Fulvestrant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 43 Neoplasm Metastasis 5 Neoplasms 4 Ovarian Neoplasms 3 Hereditary Sensory and Autonomic Neuropathies 3 Carcinoma, Non-Small-Cell Lung 3 Endometrial Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Breast Cancer Metastatic 2 Advanced Breast Cancer 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Lymphoma, Non-Hodgkin 1 Hyperglycemia 1 HER2-positive Metastatic Breast Cancer 1 HER2-positive Breast Cancer 1 Female Breast Carcinoma 1 Exanthema 1 Carcinosarcoma 1 Carcinoma, Lobular 1 Breast Neoplasms, Male 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Adenocarcinoma Of Esophagus 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02540330 2024-04-03

007

Atossa Therapeutics, Inc.

Phase 2 Terminated

3 enrolled 7 charts

Female Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡